New Times,
New Thinking.

  1. Politics
  2. Media
10 July 2011

Ed Miliband attempts to block BSkyB deal

The Labour leader calls for a cross-party vote on delaying Murdoch's take-over bid.

By Daniel Trilling

Ed Miliband will try and force a Commons vote on Wednesday to block Rupert Murdoch’s take-over of BSkyB. The Labour leader announced the plan on this morning’s Andrew Marr Show. The Observer has more details, reporting that Miliband is seeking cross-party support for a motion that will ask for the take-over bid to be delayed until the criminal investigation into the News of the World has been completed.

If the vote is successful, this could force the deal to be abandoned. As LabourList comments, many – including executives at News International – will see this as a declaration of “war” by Miliband on Murdoch’s media empire. It is also an opportunity for Miliband to put further pressure on the Prime Minister:

A source close to Ed Miliband told LabourList that “we are incredulous that David Cameron thinks he can press on with this takeover or have an NHS style delay.” They also sought so stress their view that Cameron shows “no sign of understanding the breadth of this crisis or the depth of public anger.”

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines